March 2024 FDA Recall Vancomycin Hydrochloride by Amneal Pharmaceuticals Of New York, Llc
D-0442-2024 - Superpotent Drug

This Class I drug recall was voluntarily initiated by Amneal Pharmaceuticals Of New York, Llc on March 21, 2024 for the product Vancomycin Hydrochloride. The FDA reported the reason for recall as superpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0442-2024

Reason for Recall
Superpotent Drug: Due to overfilling of drug powder
Initiated
03-21-2024
Reported
04-24-2024
Quantity
821 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Amneal Pharmaceuticals of New York, LLC
Nationwide in the USA.
Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 150 mL bottle, NDC 69238-2261-7; (c)300 mL bottle, NDC 69238-2261-5; Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807

Batch or Lot Expiration Information

Lot# (a) 22613003A, Exp. date 09/30/2025; (b) 22613004A, 22613005A, Exp. date 09/30/2025; (c) 22613005B, Exp. date 09/30/2025